A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells

被引:113
作者
Tuve, Sebastian
Wang, Hongjie
Ware, Carol
Liu, Ying
Gaggar, Anuj
Bernt, Kathrin
Shayakhmetov, Dmitry
Li, ZongYi
Strauss, Robert
Stone, Daniel
Lieber, Andre
机构
[1] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA
[2] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA
[3] Univ Washington, Dept Pathol, Seattle, WA 98195 USA
[4] Baylor Coll Med, Houston, TX 77030 USA
关键词
D O I
10.1128/JVI.01370-06
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
CD46 is used by human group B adenoviruses (Ads) as a high-affinity attachment receptor. Here we show evidence that several group B Ads utilize an additional receptor for infection of human cells, which is different from CD46. We tentatively named this receptor receptor X. Competition studies with unlabeled and labeled Ads, recombinant Ad fiber knobs, and soluble CD46 and CD46 antibodies revealed three different subgroups of group B Ads, in terms of their receptor usage. Group I (Ad16, -21, -35, and -50) nearly exclusively uses CD46. Group II (Ad3, -7p, and -14) utilizes receptor X and not CD46. Group III (Ad11p) uses both CD46 and the alternative receptor X. Interaction of group II and III Ads with receptor X occurs via the fiber knob. Receptor X is an abundantly expressed glycoprotein that interacts with group II and III Ads at relatively low affinity in a Ca2+-dependent manner. This receptor is expressed at high levels on human mesenchymal and undifferentiated embryonic stem cells, as well as on human cancer cell lines. These findings have practical implications for stem cell and gene therapy.
引用
收藏
页码:12109 / 12120
页数:12
相关论文
共 47 条
  • [1] High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus
    Anderson, BD
    Nakamura, T
    Russell, SJ
    Peng, KW
    [J]. CANCER RESEARCH, 2004, 64 (14) : 4919 - 4926
  • [2] Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease
    Barton, ES
    Youree, BE
    Ebert, DH
    Forrest, JC
    Connolly, JL
    Valyi-Nagy, T
    Washington, K
    Wetzel, JD
    Dermody, TS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (12) : 1823 - 1833
  • [3] A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication
    Bernt, K
    Liang, M
    Ye, X
    Ni, SH
    Li, ZY
    Ye, SL
    Hu, F
    Lieber, A
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (21) : 10994 - 11002
  • [4] Embryonic stem cell differentiation: The role of extracellular factors
    Czyz, J
    Wobus, AM
    [J]. DIFFERENTIATION, 2001, 68 (4-5) : 167 - 174
  • [5] Evaluation of adenovirus vectors containing serotype 35 fibers for vaccination
    DiPaolo, N
    Ni, S
    Gaggar, A
    Strauss, R
    Tuve, S
    Li, ZY
    Stone, D
    Shayakhmetov, D
    Kiviat, N
    Touré, P
    Sow, S
    Horvat, B
    Lieber, A
    [J]. MOLECULAR THERAPY, 2006, 13 (04) : 756 - 765
  • [6] The distal short consensus repeats 1 and 2 of the membrane cofactor protein CD46 and their distance from the cell membrane determine productive entry of species B adenovirus serotype 35
    Fleischli, C
    Verhaagh, S
    Havenga, M
    Sirena, D
    Schaffner, W
    Cattaneo, R
    Greber, UF
    Hemmi, S
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (15) : 10013 - 10022
  • [7] Localization of regions in CD46 that interact with adenovirus
    Gaggar, A
    Shayakhmetov, DM
    Liszewski, MK
    Atkinson, JP
    Lieber, A
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (12) : 7503 - 7513
  • [8] CD46 is a cellular receptor for group B adenoviruses
    Gaggar, A
    Shayakhmetov, DM
    Lieber, A
    [J]. NATURE MEDICINE, 2003, 9 (11) : 1408 - 1412
  • [9] Osteoinduction by ex vivo adenovirus-mediated BMP2 delivery is independent of cell type
    Gugala, Z
    Olmsted-Davis, EA
    Gannon, FH
    Lindsey, RW
    Davis, AR
    [J]. GENE THERAPY, 2003, 10 (16) : 1289 - 1296
  • [10] Integrin signalling during tumour progression
    Guo, WJ
    Giancotti, FG
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2004, 5 (10) : 816 - 826